Phase II Trial of Pramipexole vs Escitalopram for MDD in HIV Patients
A phase II trial is underway comparing pramipexole ER and escitalopram for treating MDD in HIV patients.
Company
Pharmaceutical intelligence for Cipla Ltd. with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.